Pharmaceuticals Financial News

Mumbai region have collectively bought now-banned electoral bonds worth Rs 1,344 crore since 2019. This makes up 11% of all bonds bought in India, according to an analysis by TOI. Contributions to the political parties via electoral bonds varied from Rs 2 lakh to Rs 410 crore. The buyers include builders, pharmaceutical companies, labs, diamond firms, investment and tech companies based in Mumbai, Thane, and Navi Mumbai. Even small businesses have bought these bonds, as shown by data from State Bank of India published by the Election Commission. Many were purchased in 2019, with multiple bought on a single day. Other districts like Pune, Nashik, and Kolhapur have also made significant contributions, totaling at least Rs 218 crore. This brings the total number of purchasing firms in Maharashtra to 76. The state's share in electoral bonds was Rs 1,562 crore, around 13% of all bonds bought in India.

Disaggregation & Decentralisation The healthcare services industry is witnessing two key trends: “disaggregation of general hospitals wherein focused single specialty hospital networks are offering high-quality facilities and treatments to patients, and decentralisation of healthcare, wherein hospitals are moving out of metros to tier I and II cities. “Over the next decade or so a lot of value is going to be destroyed and created depending on how industry participants react to these trends," Hari said. He observed that the legacy model of large general hospitals in big cities was perhaps a result of low population density, absence of social infrastructure and low purchasing power in the smaller cities.

Bannari Amman Sugars Ltd.(up 2.05%), Ponni Sugars(Erode)Ltd.(up 1.14%) and Ugar Sugar Works Ltd.(up 0.74%) were among the top gainers.

Cipla executive Vikram Sudarsan, will now invest the capital to support its product pipeline for neuropsychiatric and neurodevelopmental disorders. This marks one of the largest early-stage funding rounds of a clinical-stage pharmaceutical company. The round was co-led by new investors F-Prime Capital, Forbion, and Norwest Venture Partners.

(Reuters) -International Flavors & Fragrances said on Tuesday it would sell its pharma solutions business to French plant-based ingredients maker Roquette for an enterprise value of $2.85 billion, as it looks to focus on higher-margin businesses.

KCP Sugar & Industries Corporation Ltd.(up 5.45%), KM Sugar Mills Ltd.(up 2.64%), Uttam Sugar Mills Ltd.(up 1.91%), Shree Renuka Sugars Ltd.(up 1.57%), Balrampur Chini Mills Ltd.(up 0.90%), EID Parry(India)Ltd.(up 0.74%), Triveni Engineering & Industries Ltd.(up 0.48%), Vishwaraj Sugar Industries Ltd.(up 0.32%), Dwarikesh Sugar Industries Ltd.(up 0.32%) and Ugar Sugar Works Ltd.(up 0.08%) stood among the top gainers.

Shares of Pfizer Ltd.(up 2.89 per cent), Gland Pharma Ltd.(up 2.36 per cent), Alkem Laboratories Ltd.(up 1.21 per cent), Abbott India Ltd.(up 0.35 per cent) and Laurus Labs Ltd.(up 0.08 per cent) ended the day as top gainers in the pack.

Eris Lifesciences Ltd. with a target price of Rs 930. The current market price of Eris Lifesciences Ltd. is Rs 846. Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 11507.99 Crore) operating in Pharmaceuticals sector.

NEW DELHI : Novartis India, the local arm of Swiss pharma giant Novartis AG, is in discussions to secure a distribution partner for the imminent launch of Asciminib, the first-in-class treatment for chronic myeloid leukemia (CML) targeting the ABL myristoyl pocket (STAMP), Amitabh Dube, the company's country president and managing director, said. “Innovative therapies introduced over the past two decades have revolutionized treatment for people with CML, a serious and life-threatening blood disorder. Novartis, known for developing targeted therapies for CML, is now launching Asciminib, the first CML treatment that works by specifically targeting the ABL Myristoyl pocket," Dube told Mint in an email interaction.

In Thursday’s trading session, the following five stocks witnessed a build of fresh long positions. Lets first understand how this conclusion is reached that whether the stock has seen a buildup of fresh long position or not. When the stock prices move up and open interest on the counter also moves upward, it is taken as a sign of a long buildup. The signal is considered more reliable if the volume on the counter has also seen an increase.

Eris Lifesciences with a target price of Rs 1070. The current market price of Eris Lifesciences Ltd. is Rs 860.15. Eris Lifesciences Ltd., incorporated in the year 2007, is a Mid Cap company (having a market cap of Rs 11707.95 Crore) operating in Pharmaceuticals sector.

Investing.com -- Here are stocks making moves in premarket U.S. trading on Tuesday. Please check back later for updates:

MILAN (Reuters) — Automaker Toyota Motor (NYSE:TM) Corp became the most shorted large-cap stock by hedge funds in the Asia Pacific region in February, overtaking Takeda Pharmaceutical, a report from data firm Hazeltree showed on Tuesday.

India-EFTA trade deal: In a landmark deal with the European Free Trade Association (EFTA), India has signed a trade and economic partnership agreement (TEPA) to boost trade and investments for developed countries- Iceland, Liechtenstein, Norway, and Switzerland. Under the agreement, the four-member EFTA has committed $100 billion in investments in India and the tariffs between both blocs are expected to reduce.

IIT Madras) is collaborating with Indian space startup Vellon Space to advance extra-terrestrial manufacturing research and development. The collaboration marks a significant milestone in orbital ‘microgravity research’.

In Monday’s trading session, the following five stocks witnessed a build of fresh long positions. Lets first understand how this conclusion is reached that whether the stock has seen a buildup of fresh long position or not. When the stock prices move up and open interest on the counter also moves upward, it is taken as a sign of a long buildup. The signal is considered more reliable if the volume on the counter has also seen an increase.

investment decision. BASIC FACTS DATE OF LAUNCH 7 SEPTEMBER 2010 CATEGORY

free trade pact with a four-member European bloc, Norway on Sunday said it will eliminate customs duties for almost 98 per cent of the imports from India under the framework of the pact. The ambitious trade pact, signed between India and the European Free Trade Association (EFTA) comprising Norway, Switzerland, Iceland and Liechtenstein, aims to expand trade across a range of areas including pharmaceuticals, manufacturing, new technologies and machinery. After the EEA (European Economic Area) agreement, this could become one of the most important trade agreements Norway has ever entered, said Norwegian Prime Minister Jonas Gahr Stoere. At a media briefing, Norway's Minister of Trade and Industry Jan Christian Vestre described the Trade and Economic Partnership Agreement (TEPA) as a major result-oriented milestone that would not only boost two-way trade but also promote a rules-based trading system.

US Food and Drug Administration's concentration limit for benzene by more than 800 times. Valisure arrived at the findings after elaborate tests during which benzoyl peroxide acne products were stored at high temperatures. As per a CNN report, the researchers left the products in a car for 14 days with temperature as high as 150 degrees Fahrenheit.

India signed a free trade pact on Sunday with a group of European nations — Switzerland, Norway, Iceland and Liechtenstein — committing to reduce tariffs, while New Delhi receives $100 billion in investments over the next 15 years. India and the members of the European Free Trade Association (EFTA) held 21 rounds of talks over 16 years to clinch the broad-based Trade and Investment Agreement. Here are key facts about the trade pact:

Dive into the world of savvy investing with InvestingPro! We're giving you this eye-opening article for FREE, showcasing pro-level insights in real-time. Seize the opportunity and upgrade today with promo code HOT2024 for an additional 10% off already discounted rates (save up to 50%). Time is ticking – upgrade now with just a click.